Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| System biology approaches identified novel biomarkers and their signaling pathways involved in renal cell carcinoma with different human diseases. | Biosci Rep | 2022 | 36314741 | PubTator, text mining | PubMed |
| Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis. | Front Pharmacol | 2022 | 36313291 | PubTator, text mining | PubMed |
| Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers. | World J Gastrointest Oncol | 2022 | 36310704 | PubTator, text mining | PubMed |
| DNA methylation alternation in Stanford- A acute aortic dissection. | BMC Cardiovasc Disord | 2022 | 36309656 | PubTator, text mining | PubMed |
| ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. | Nat Commun | 2022 | 36307405 | PubTator, text mining | PubMed |
| Autosomal recessive LRP1-related syndrome featuring cardiopulmonary dysfunction, bone dysmorphology, and corneal clouding. | Cold Spring Harb Mol Case Stud | 2022 | 36307211 | PubTator, text mining | PubMed |
| Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume II. | Front Genet | 2022 | 36299589 | PubTator, text mining | PubMed |
| Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. | Pharmaceutics | 2022 | 36297426 | PubTator, text mining | PubMed |
| Autoimmune Pancreatitis: From Pathogenesis to Treatment. | Int J Mol Sci | 2022 | 36293522 | PubTator, text mining | PubMed |
| Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer. | Int J Mol Sci | 2022 | 36293126 | PubTator, text mining | PubMed |
| Recent Advances in the Aging Microenvironment of Breast Cancer. | Cancers (Basel) | 2022 | 36291773 | PubTator, text mining | PubMed |
| Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis. | Biomolecules | 2022 | 36291728 | PubTator, text mining | PubMed |
| Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. | Biomedicines | 2022 | 36289620 | PubTator, text mining | PubMed |
| Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease. | Circ Res | 2022 | 36285625 | PubTator, text mining | PubMed |
| A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma. | J Oncol | 2022 | 36276289 | PubTator, text mining | PubMed |
| Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study. | Front Immunol | 2022 | 36275770 | PubTator, text mining | PubMed |
| Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma. | Front Immunol | 2022 | 36275743 | PubTator, text mining | PubMed |
| Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma. | Clin Proteomics | 2022 | 36266629 | PubTator, text mining | PubMed |
| Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies. | Int J Biol Sci | 2022 | 36263163 | PubTator, text mining | PubMed |
| LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis. | Oxid Med Cell Longev | 2022 | 36254230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=30